메뉴 건너뛰기




Volumn 213, Issue 6, 1999, Pages 360-366

Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion

Author keywords

Frontloading thrombolytic therapy; Hemodilution; Ischemic central retinal vein occlusion; Recombinant tissue plasminogen activator

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; HETASTARCH; PENTOXIFYLLINE;

EID: 0032741180     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027455     Document Type: Article
Times cited : (39)

References (40)
  • 2
    • 0020520636 scopus 로고
    • Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion
    • Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF: Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90:488-506.
    • (1983) Ophthalmology , vol.90 , pp. 488-506
    • Hayreh, S.S.1    Rojas, P.2    Podhajsky, P.3    Montague, P.4    Woolson, R.F.5
  • 3
    • 0018740720 scopus 로고
    • The natural course of central retinal vein occlusion
    • Zegarra H, Gutman FA, Conforto J: The natural course of central retinal vein occlusion. Ophthalmology 1979;86:1931-1942.
    • (1979) Ophthalmology , vol.86 , pp. 1931-1942
    • Zegarra, H.1    Gutman, F.A.2    Conforto, J.3
  • 4
    • 0028802678 scopus 로고
    • A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion
    • Central Vein Occlusion Study Group N Report
    • Central Vein Occlusion Study Group N Report: A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 1995;102: 1434-1444.
    • (1995) Ophthalmology , vol.102 , pp. 1434-1444
  • 5
    • 0031955016 scopus 로고    scopus 로고
    • Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion
    • Chen HC, Wiek J, Gupta A, Luckie A, Kohner EM: Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998;82:162-167.
    • (1998) Br J Ophthalmol , vol.82 , pp. 162-167
    • Chen, H.C.1    Wiek, J.2    Gupta, A.3    Luckie, A.4    Kohner, E.M.5
  • 6
    • 0024311203 scopus 로고
    • A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution
    • Hansen LL, Wiek J, Wiederholt M: A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989;73:895-899.
    • (1989) Br J Ophthalmol , vol.73 , pp. 895-899
    • Hansen, L.L.1    Wiek, J.2    Wiederholt, M.3
  • 10
    • 0019768239 scopus 로고
    • Central retinal vein occlusion. A prospective histopathologic study of 29 eyes in 28 cases
    • Green WR, Chan CC, Hutchins GM, Terry JM: Central retinal vein occlusion. A prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27-55.
    • (1981) Retina , vol.1 , pp. 27-55
    • Green, W.R.1    Chan, C.C.2    Hutchins, G.M.3    Terry, J.M.4
  • 11
    • 0018938932 scopus 로고
    • Clinicopathologic case report of bilateral central retinal vein occlusion in Reye's syndrome
    • Smith P, Green WR, Miller NR, Terry JM: Clinicopathologic case report of bilateral central retinal vein occlusion in Reye's syndrome. Arch Ophthalmol 1980;98:1256-1260.
    • (1980) Arch Ophthalmol , vol.98 , pp. 1256-1260
    • Smith, P.1    Green, W.R.2    Miller, N.R.3    Terry, J.M.4
  • 12
    • 0023258694 scopus 로고
    • Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
    • Chesebro JH, Knatterud G, Roberts R: Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge. Circulation 1987;76:142-154.
    • (1987) Circulation , vol.76 , pp. 142-154
    • Chesebro, J.H.1    Knatterud, G.2    Roberts, R.3
  • 13
    • 0026607185 scopus 로고
    • ISIS-3: A randomised comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected myocardial infarction
    • ISIS-3 (Third International Study of Infarct Survival) Collaborative Group: ISIS-3: A randomised comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected myocardial infarction. Lancet 1993;339:753-770.
    • (1993) Lancet , vol.339 , pp. 753-770
  • 14
    • 0027240597 scopus 로고
    • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
    • The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
    • (1993) N Engl J Med , vol.329 , pp. 673-682
  • 15
    • 0027424433 scopus 로고
    • The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
    • The GUSTO angiographic investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329: 1615-1622.
    • (1993) N Engl J Med , vol.329 , pp. 1615-1622
  • 16
    • 0021989853 scopus 로고
    • Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Report from the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator
    • Verstraete M, Bernard R, Bory M: Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Report from the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator. Lancet 1985;i:842-847.
    • (1985) Lancet , vol.1 , pp. 842-847
    • Verstraete, M.1    Bernard, R.2    Bory, M.3
  • 17
    • 0027446870 scopus 로고
    • Alteplase versus heparin in acute pulmonary embolsim: Randomised trial assessing right-ventricular function and pulmonary perfusion
    • Goldhaber SZ: Alteplase versus heparin in acute pulmonary embolsim: Randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507-511.
    • (1993) Lancet , vol.341 , pp. 507-511
    • Goldhaber, S.Z.1
  • 18
    • 0025274774 scopus 로고
    • Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis
    • Goldhaber SZ, Meyerovitz MF, Green D: Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990;88:235-240.
    • (1990) Am J Med , vol.88 , pp. 235-240
    • Goldhaber, S.Z.1    Meyerovitz, M.F.2    Green, D.3
  • 19
    • 0028783948 scopus 로고
    • Tissue plasminogen activator for acute ischemic stroke
    • The National Institute of Neurological Disorders and Stroke rt-PA Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
    • (1995) N Engl J Med , vol.333 , pp. 1581-1587
  • 20
    • 0032537068 scopus 로고    scopus 로고
    • A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs
    • The Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators: A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med 1998;338:1105-1111.
    • (1998) N Engl J Med , vol.338 , pp. 1105-1111
  • 21
    • 0032138123 scopus 로고    scopus 로고
    • Systemische Lysetherapie bei retinalen Gefässverschlüssen
    • Hattenbach LO: Systemische Lysetherapie bei retinalen Gefässverschlüssen. Ophthalmologe 1998;95:568-575.
    • (1998) Ophthalmologe , vol.95 , pp. 568-575
    • Hattenbach, L.O.1
  • 22
    • 0031716493 scopus 로고    scopus 로고
    • Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion
    • Hattenbach LO, Steinkamp GWK, Scharrer I, Ohrloff C: Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica 1998; 212:394-398.
    • (1998) Ophthalmologica , vol.212 , pp. 394-398
    • Hattenbach, L.O.1    Steinkamp, G.W.K.2    Scharrer, I.3    Ohrloff, C.4
  • 23
    • 0017231611 scopus 로고
    • Streptokinase in central retinal vein occlusion: A controlled clinical trial
    • Kohner EM, Pettit JE, Hamilton AM: Streptokinase in central retinal vein occlusion: A controlled clinical trial. Br Med J 1976;1:550-553.
    • (1976) Br Med J , vol.1 , pp. 550-553
    • Kohner, E.M.1    Pettit, J.E.2    Hamilton, A.M.3
  • 26
    • 0026742376 scopus 로고
    • Urgent therapy for stroke. I. Pilot study of tissue plasminogen activator administered within 90 minutes
    • Brott TG, Haley EC Jr, Levy DE: Urgent therapy for stroke. I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632-640.
    • (1992) Stroke , vol.23 , pp. 632-640
    • Brott, T.G.1    Haley Jr., E.C.2    Levy, D.E.3
  • 27
    • 0026639662 scopus 로고
    • Urgent therapy for stroke. II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset
    • Haley EC Jr, Levy DE, Brott TG: Urgent therapy for stroke. II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992;23:641-645.
    • (1992) Stroke , vol.23 , pp. 641-645
    • Haley Jr., E.C.1    Levy, D.E.2    Brott, T.G.3
  • 28
    • 0031674570 scopus 로고    scopus 로고
    • Heparin cofactor II deficiency in central retinal vein occlusion
    • Hattenbach LO, Klais C, Scharrer I: Heparin cofactor II deficiency in central retinal vein occlusion. Acta Ophthalmol Scand 1998;76: 758-759.
    • (1998) Acta Ophthalmol Scand , vol.76 , pp. 758-759
    • Hattenbach, L.O.1    Klais, C.2    Scharrer, I.3
  • 30
    • 0023875143 scopus 로고
    • Behandlungsversuche der Zentralvenenthrombose der Netzhaut mit Plasminogen-Aktivator (rt-PA)
    • Reim M, Bertram B, Wolf S: Behandlungsversuche der Zentralvenenthrombose der Netzhaut mit Plasminogen-Aktivator (rt-PA). Klin Wochenschr 1988;66:143-149.
    • (1988) Klin Wochenschr , vol.66 , pp. 143-149
    • Reim, M.1    Bertram, B.2    Wolf, S.3
  • 31
    • 0031733169 scopus 로고    scopus 로고
    • Ultrasound enhanced thrombolysis in experimental retinal vein occlusion in the rabbit
    • Larsson J, Carlson J, Olsson SB: Ultrasound enhanced thrombolysis in experimental retinal vein occlusion in the rabbit. Br J Ophthalmol 1998;82:1438-1440.
    • (1998) Br J Ophthalmol , vol.82 , pp. 1438-1440
    • Larsson, J.1    Carlson, J.2    Olsson, S.B.3
  • 32
    • 0024507916 scopus 로고
    • Tissue plasminogen activator in the treatment of experimental retinal vein occlusion
    • Oncel M, Peyman GA, Khoobehi B: Tissue plasminogen activator in the treatment of experimental retinal vein occlusion. Retina 1989; 9:1-7.
    • (1989) Retina , vol.9 , pp. 1-7
    • Oncel, M.1    Peyman, G.A.2    Khoobehi, B.3
  • 35
    • 0029927375 scopus 로고    scopus 로고
    • Activated protein C resistance in young adults with central retinal vein occlusion
    • Larsson J, Olafsdottir E, Bauer B: Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996;80:200-202.
    • (1996) Br J Ophthalmol , vol.80 , pp. 200-202
    • Larsson, J.1    Olafsdottir, E.2    Bauer, B.3
  • 37
    • 0025812589 scopus 로고
    • Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis
    • Anderson JL, Karagounis L, Allan A, Bradford MJ, Menlove RL, Pryor TA: Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol 1991;68:166-170.
    • (1991) Am J Cardiol , vol.68 , pp. 166-170
    • Anderson, J.L.1    Karagounis, L.2    Allan, A.3    Bradford, M.J.4    Menlove, R.L.5    Pryor, T.A.6
  • 38
    • 0024441545 scopus 로고
    • The use of tissue plasminogen activator for acute myocardial infarction in the elderly: Results from the Thrombolysis in Myocardial Infarction Phase I Open-Label Studies, and the Thrombolysis in Myocardial Infarction Phase II Pilot Study
    • Chaitman BR, Thompson B, Wittry MD, Stump D, Hamilton WP, Hillis LD, Dwyer JG, Solomon RE, Knatterud GL for the TIMI Investigators: The use of tissue plasminogen activator for acute myocardial infarction in the elderly: Results from the Thrombolysis in Myocardial Infarction Phase I Open-Label Studies, and the Thrombolysis in Myocardial Infarction Phase II Pilot Study. J Am Coll Cardiol 1989; 14:1159-1165.
    • (1989) J Am Coll Cardiol , vol.14 , pp. 1159-1165
    • Chaitman, B.R.1    Thompson, B.2    Wittry, M.D.3    Stump, D.4    Hamilton, W.P.5    Hillis, L.D.6    Dwyer, J.G.7    Solomon, R.E.8    Knatterud, G.L.9
  • 39
    • 0026100158 scopus 로고
    • Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study: Thrombolysis in Myocardial Infarction; Phase II, Pilot and Clinical Trial
    • Gore JM, Sloan M, Price TR, Randall AMY, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML, and the TIMI Investigators: Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study: Thrombolysis in Myocardial Infarction; Phase II, Pilot and Clinical Trial. Circulation 1991;83:448-459.
    • (1991) Circulation , vol.83 , pp. 448-459
    • Gore, J.M.1    Sloan, M.2    Price, T.R.3    Randall, A.M.Y.4    Bovill, E.5    Collen, D.6    Forman, S.7    Knatterud, G.L.8    Sopko, G.9    Terrin, M.L.10
  • 40
    • 0026507306 scopus 로고
    • Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis
    • Sloan M, Gore JM: Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis. Am J Cardiol 1992;69:21A-38A.
    • (1992) Am J Cardiol , vol.69
    • Sloan, M.1    Gore, J.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.